DALLAS, Jan. 26, 2016 /PRNewswire/ -- CLn® Skin Care, offering a line of physician-developed products formulated to therapeutically cleanse and soothe skin prone to eczema, acne and other common skin infections, announces its appointment of Stefano Curti to its Board of Directors. Mr. Curti brings over 25 years of experience in health, wellness, beauty, baby and OTC brand escalation. Prior to joining CLn® Skin Care, Mr. Curti held the positions of Global President, Johnson & Johnson's Beauty and Baby divisions and Global President Consumer Healthcare at Pfizer. More recently he held the position of Senior Advisor and Board Member for private equity and venture capital firms focused on consumer companies.
"We are pleased that patented CLn® washes are available to many people in need of effective and safe therapeutic skin cleansers," said Dr. Anwar, Founder and Chairman of CLn® Skin Care. "Stefano's vast experience in consumer marketing and commercialization in health, beauty and baby categories will be invaluable to our company. His work with multinational brands such as Neutrogena, Aveeno and Lubriderm will play a key role in expanding our reach to those with compromised skin."
"I am a strong believer in good, therapeutic cleansing as the first building block for healthier skin," said Stefano Curti. "I believe CLn® Skin Care is creating a new category in the market and is providing a higher service to patients, doctors and a higher quality of life to consumers in general."
Mr. Curti earned his degree in business economics from LUISS Guido Carli University.
About CLn® Skin Care
Designed by physicians, CLn® Skin Care products are therapeutic washes uniquely formulated for skin prone to eczema, folliculitis, acne and other infections that trouble millions of adults and children. Preserved with sodium hypochlorite, CLn® Skin Care offers the effectiveness of a bleach bath with the luxury of gentle cleansing in the form of body washes and shampoos. CLn® can be used on compromised or sensitive skin without causing irritation or dryness and reduces the appearance of redness and oftentimes "scaly" skin associated with eczema (atopic dermatitis). CLn® Skin Care has been clinically tested and is safe to use on children 6 months of age and older. For more information, visit: www.clnwash.com.
SOURCE CLn Skin Care